Related Articles
Crizotinib may be used in lewis lung carcinoma: A novel use for crizotinib
A real‑world study of treatment patterns and survival outcome in advanced anaplastic lymphoma kinase‑positive non‑small‑cell lung cancer
Response to alectinib after one year of discontinuation of crizotinib in anaplastic lymphoma kinase-positive non-small-cell lung cancer: A case report
Role of <em>STK11</em> in <em>ALK</em>‑positive non‑small cell lung cancer (Review)
ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues